This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

135 Resources
135 Resources
135 Resources
    Date
  1. Private companies have limited incentive to develop products that address poverty-related diseases such as malaria, HIV, and tuberculosis because the chances of technical failure during development are high and the potential for profit may be minimal. But over the past two decades, a critical tool has emerged to help address this gap: the product development partnership(PDP), which brings together public, private, academic, and philanthropic expertise and funding to develop and deliver global health products that would otherwise have little or no chance of coming to market. Many of these PDPs take a portfolio-based approach, spreading investments among multiple companies to increase the probability that at least one viable product will emerge to meet the need. This paper examines one successful PDP effort, PATH’s G6PD Diagnostic Initiative, to highlight key factors that can lead to challenges and contribute to success. Although each PDP is unique, and PDPs can vary greatly in scale, scope, and the number and configuration of partners, many of the lessons from this initiative are broadly applicable to other global health efforts and may be helpful to funders, product developers, policymakers, and researchers as they consider engaging in PDPs.
    Published: January 2022
    Type: Resource Page
  2. The Safeprim study evaluated the operational aspects of the SD Biosensor STANDARD™ G6PD screening test performed in real-life settings of two municipalities in the Brazilian Amazon. In order to provide suitable training for health care professionals with different backgrounds at the primary level of care, job aids were created based on materials available within the G6PD Operational Research Community of Practice hosted by PATH. This way, the essential information on test procedure, treatment choice, and pharmacovigilance of hemolysis could be used in the field after a 4-hour training session.A wall poster (29.7x42 cm), folder (21x29.7 cm), and slide set were used during the trainings, while patient cards (8x20 cm malaria card) containing G6PD and malaria data were provided after screening: a green-colored card for normal G6PD status and red-colored card for G6PD deficient. Such cards could be referenced in future malaria episodes.
    Published: December 2021
    Type: Resource Page
  3. A review of G6PD deficiency and testing and an introduction to a point-of-care quantitative diagnostic screening tool for G6PD - the SDB STANDARD G6PD Test.
    Published: November 2021
    Type: Resource Page
  4. Interpreting results of the SD BIOSENSOR STANDARD G6PD Test
    Published: November 2021
    Type: Resource Page
  5. SD Biosensor STANDARD G6PD Test Quality Assurance Guide
    Published: November 2021
    Type: Resource Page
Load more